Turkish private equity group invests $39M to support Harvard researcher’s next-gen obesity antibodies

As Harvard University reels from extensive cuts to federal funding by the Trump Administration, one researcher there has secured his lab’s future by looking abroad. Gökhan Hotamışlıgil, M.D., Ph.D., has secured about $39 million from a Turkish investment group to support the next 10 years of his group’s research on new antibodies for obesity and other metabolic diseases.

Jun 16, 2025 - 19:00
 0
Turkish private equity group invests $39M to support Harvard researcher’s next-gen obesity antibodies
As Harvard University reels from extensive cuts to federal funding by the Trump Administration, one researcher there has secured his lab’s future by looking abroad. Gökhan Hotamışlıgil, M.D., Ph.D., has secured about $39 million from a Turkish investment group to support the next 10 years of his group’s research on new antibodies for obesity and other metabolic diseases.